NEW YORK, Sept. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Intravenous (IV) Solutions Industry
http://www.reportlinker.com/p0611078/Global-Intravenous-IV-Solutions-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_E
This report analyzes the worldwide markets for Intravenous (IV) Solutions in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 34 companies including many key and niche players such as B. Braun Melsungen AG, Baxter International, Inc., Baxter India Private Limited, Claris Lifesciences Ltd., Fresenius SE & Co. KGaA, Fresenius Kabi AG, Galenica Ltd., Grifols S.A., Hospira, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Liqvor Pharmaceuticals, Marck Biosciences Ltd., Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., Sino-Swed Pharmaceutical, Terumo Corporation, and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
2. INDUSTRY OVERVIEW 4
IV Solutions: Steady Growth Prospects 4
Current and Future Analysis 4
Healthcare Industry: Impact of Recession 5
The Need for Low-Cost Solutions 5
Clinical Nutrition - Addressing Patients' Nutritional
Requirements 5
Global Parenteral Nutrition Market 6
Table 1: Leading Players in the Global Parenteral Nutrition
Market (2010E): Percentage Share Breakdown of Value Sales for
Baxter, Fresenius Kabi, B. Braun Melsungen, Hospira, and
Others (includes corresponding Graph/Chart) 6
Peripheral Intravenous Feeding Vs Central Venous Feeding 7
Intravenous Iron Drugs Market - An Overview 7
3. AN INTRODUCTION TO INTRAVENOUS THERAPY 8
Intravenous Therapy 8
Volume Expanders - Colloids and Crystalloids 8
Blood and Blood-Based Products 8
Medications 9
4. INTRAVENOUS SOLUTIONS 10
Defining Intravenous Solutions 10
Tonicity and Osmolality 10
Production of IV Solutions 11
Types of IV Solutions 11
Colloid Solutions 11
Crystalloid Solutions 11
Properties of IV Solution Type Based on Concentration 12
Isotonic Crystalloids 12
Hypertonic Crystalloids 12
Hypotonic Crystalloids 13
Commonly Used Crystalloid Solutions 13
Saline Solution 13
Normal Saline 13
Half-Normal Saline 14
Quarter-Normal Saline 14
Hypertonic Saline 14
Dextrose 14
Saline with Additional Ingredients 14
Intravenous Sugar Solution 14
Dextrose Solutions or D5W 15
Other Types 15
Pre-mixed IV Solutions 15
Large and Small Volume Intravenous Solutions 15
Devices Used in IV Solutions Administration 16
Types of Intravenous Access Devices 16
Peripheral Cannula 17
Central IV Lines 17
Implantable Ports 17
Tunneled Lines 17
Peripherally Inserted Central Catheter (PICC) 17
IV Fluid Packaging 18
Possible Risks in Intravenous Therapy 18
Embolism 18
Electrolyte Imbalance 18
Extravasation/Infiltration 19
Phlebitis 19
Infection 19
5. INTRAVENOUS NUTRITIONAL THERAPY 20
An Introduction 20
Parenteral Nutrition 21
Routes of Application 22
Types of Parenteral Nutrition Solutions 22
Total Parenteral Nutrition (TPN) 22
Daily Requirements for Total Parenteral Nutrition in Adults 23
Partial Parenteral Nutrition (PPN) 23
Home Parenteral Nutrition 24
Classification of Parenteral Nutrition by Type of Nutrients 24
Amino Acids 24
Carbohydrates 24
Lipids 25
Minerals & Electrolytes 25
Micronutrients 26
Vitamins 26
Trace Elements 27
Large and Small Volume Parenteral (LVP) Solutions 27
Large Volume Parenteral Solutions 27
Small Volume Parenteral (SVP) Solutions 28
IV Fat Emulsions - Enabling Maintenance of Bodyweight 28
6. PRODUCT LAUNCHES 29
Bioniche Introduces Mefoxin® Premix IV Solution 29
Marck Biosciences Introduces Paracetamol IV in Plastic Pack 29
Grifols Introduces Flebogamma® 10% DIF in the US 29
Grifols Introduces Niuliva® 29
Galenica Launches Ferinject in Europe 30
B. Braun Unveils New Infusion Pumps in the US 30
7. RECENT INDUSTRY ACTIVITY 31
Pfizer Takes Over King Pharmaceuticals 31
Grifols to Set Up Form-Fill-Seal Production Lines for
Parenteral Solutions 31
FMC and Vifor Pharma Team Up to Form Vifor Fresenius 31
Marck Biosciences Snaps Up Injectible Facility of Ravish Infusion 32
Lijun Forms JV with Tonghua Dongbao Pharmaceuticals 32
ADIH and Bram S.p.A. Ink Agreement for Wellpharma's IV
Production Facility 32
Hospira Signs Multi-product Agreements with MedAssets 32
Hospira Enters into Agreements with Novation 33
Prism Pharmaceuticals Obtains FDA approval for NEXTERONE® 33
Mission Health System Commences Production of RIVA-produced IV
Solution 33
Mission Health Systems Selects Automation Solution from HIS 34
Applied Research Associates Bags Contract for Packaged
Intravenous Fluids 34
Bivigam™ Dossier Submitted to US FDA by Biotest 34
Grifols Bags EMA License for Marketing Flebogamma® DIF 100mg/ml 34
Hospira Announces Migration to Non-DEHP Based IV
Administration Units 35
Grifols and Health Robotics Ink Collaboration Agreement 35
Marck Biosciences Obtains Approval for Low Volume Parenteral
Plant 35
Grifols Receives Approval for Sterile Albumin Filling Unit 36
Grifols Establishes New Production Unit 36
Fresenius Medical to Form JV with Galenica 36
B. Braun Inks Agreement with Health Robotics 36
Fresenius Medical Care Closes Agreement with Luitpold
Pharmaceuticals 36
Grifols Receives Approval for Intravenous Immunoglobulin
Flebogamma® DIF 37
8. FOCUS ON SELECT PLAYERS 38
B. Braun Melsungen AG (Germany) 38
Baxter International, Inc. (US) 38
Baxter India Private Limited (India) 39
Claris Lifesciences Ltd. (India) 39
Fresenius SE & Co. KGaA (Germany) 39
Fresenius Kabi AG (Germany) 40
Galenica Ltd. (Switzerland) 40
Grifols S.A. (Spain) 40
Hospira, Inc. (US) 41
Sichuan Kelun Pharmaceutical Co., Ltd. 41
Liqvor Pharmaceuticals (Armenia) 42
Marck Biosciences Ltd. (India) 42
Otsuka Pharmaceutical Co. Ltd. (Japan) 42
Pfizer, Inc. (US) 43
Sino-Swed Pharmaceutical (China) 43
Terumo Corporation (Japan) 43
Watson Pharmaceuticals, Inc. (US) 44
9. GLOBAL MARKET PERSPECTIVE 45
Table 2: World Recent Past, Current and Future Analysis for
Intravenous Solutions by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America, and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for the Years 2009 through 2017 (includes
corresponding Graph/Chart) 45
Table 3: World Historic Review for Intravenous Solutions by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2003 through 2008 (includes corresponding Graph/Chart) 46
Table 4: World 15-Year Perspective for Intravenous Solutions
by Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America, and
Rest of World Markets for the Years 2003, 2010 and 2017
(includes corresponding Graph/Chart) 47
10. THE UNITED STATES 48
A.Market Analysis 48
Outlook 48
Market Overview 48
Table 5: US Population by Age Group and Gender (2010E)
(includes corresponding Graph/Chart) 48
B.Market Analytics 49
Table 6: US Recent Past, Current and Future Analysis for
Intravenous Solutions Analyzed with Annual Sales Figures in
US$ Million for the Years 2009 through 2017 (includes
corresponding Graph/Chart) 49
Table 7: US Historic Review for Intravenous Solutions
Analyzed with Annual Sales Figures in US$ Million for the
Years 2003 through 2008 (includes corresponding Graph/Chart) 49
11. CANADA 50
Market Analysis 50
Table 8: Canadian Recent Past, Current and Future Analysis
for Intravenous Solutions Analyzed with Annual Sales Figures
in US$ Million for the Years 2009 through 2017 (includes
corresponding Graph/Chart) 50
Table 9: Canadian Historic Review for Intravenous Solutions
Analyzed with Annual Sales Figures in US$ Million for the
Years 2003 through 2008 (includes corresponding Graph/Chart) 50
12. JAPAN 51
Market Analysis 51
Table 10: Japanese Recent Past, Current and Future Analysis
for Intravenous Solutions Analyzed with Annual Sales Figures
in US$ Million for the Years 2009 through 2017 (includes
corresponding Graph/Chart) 51
Table 11: Japanese Historic Review for Intravenous Solutions
Analyzed with Annual Sales Figures in US$ Million for the
Years 2003 through 2008 (includes corresponding Graph/Chart) 51
13. EUROPE 52
Market Analysis 52
Table 12: European Recent Past, Current and Future Analysis
for Intravenous Solutions by Geographic Region - France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for the Years 2009 through 2017 (includes
corresponding Graph/Chart) 52
Table 13: European Historic Review for Intravenous Solutions
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for the Years 2003
through 2008 (includes corresponding Graph/Chart) 53
Table 14: European 15-Year Perspective for Intravenous
Solutions by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia,
and Rest of Europe Markets for the Years 2003, 2010 and 2017
(includes corresponding Graph/Chart) 54
14. ASIA-PACIFIC 55
A.Market Analysis 55
Outlook 55
IV Solutions Market in China 55
Table 15: IV Solutions Products Packaging in China (2009):
Percentage Share Breakdown of Volume Sales for Glass
Bottles, and Plastic Bottles & Non-PVC Soft Bags 55
B.Market Analytics 56
Table 16: Asia-Pacific Recent Past, Current and Future
Analysis for Intravenous Solutions Analyzed with Annual
Sales Figures in US$ Million for the Years 2009 through 2017
(includes corresponding Graph/Chart) 56
Table 17: Asia-Pacific Historic Review for Intravenous
Solutions Analyzed with Annual Sales Figures in US$ Million
for the Years 2003 through 2008 (includes corresponding
Graph/Chart) 56
15. LATIN AMERICA 57
Market Analysis 57
Table 18: Latin American Recent Past, Current and Future
Analysis for Intravenous Solutions Analyzed with Annual
Sales Figures in US$ Million for the Years 2009 through 2017
(includes corresponding Graph/Chart) 57
Table 19: Latin American Historic Review for Intravenous
Solutions Analyzed with Annual Sales Figures in US$ Million
for the Years 2003 through 2008 (includes corresponding
Graph/Chart) 57
16. REST OF WORLD 58
A.Market Analysis 58
Outlook 58
Middle East 58
Uganda 58
B.Market Analytics 59
Table 20: Rest of World Recent Past, Current and Future
Analysis for Intravenous Solutions Analyzed with Annual
Sales Figures in US$ Million for the Years 2009 through 2017
(includes corresponding Graph/Chart) 59
Table 21: Rest of World Historic Review for Intravenous
Solutions Analyzed with Annual Sales Figures in US$ Million
for the Years 2003 through 2008 (includes corresponding
Graph/Chart) 59
COMPETITIVE LANDSCAPE
Total Companies Profiled: 34 (including Divisions/Subsidiaries - 46)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 13
Canada 1
Japan 1
Europe 14
France 2
Germany 5
The United Kingdom 2
Spain 1
Rest of Europe 4
Asia-Pacific (Excluding Japan) 15
Middle-East 1
Africa 1
------------------------------------------
To order this report:
Medical Equipment and Supply Industry: Global Intravenous (IV) Solutions Industry
Medical Equipment and Supply Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article